1. What can Transfer Factor do for you?2BOOSTS Natural Killer Cellsor NK cells are part ofthe immunesystem.Its Primary responsibility is to seek and destroy cancer cells.A Weak immune system can lead to chronic ailments, infections,degenerative diseases, and cancer.

2. Evidence from Clinical Studies7 years Scientific Study on 196 productsTEST RESULTS PUBLISHED IN JANA (Journal of American Nutraceutical Association) TOP 12 PRODUCTS1 TRANSFER FACTOR ADV Immune (NK Cell) ActivityTransfer Factor is PLUS ...437%2TRANSFER FACTOR ADV ....900% MORE 437%3. 283% MANGOSTEEN .. 76%POWERFULthan any other4. IP-6 . 49%supplement known to5. PLANT POLYSACCHARIDES.....48%science!283%6. ECHINACEA 43%7. SHITAKE MUSHROOM 42%8. CORDYCEPS FORMULA 28%9. BOVINE COLOSTRUM/ IgG ............23%10. PHYTONUTRIENT FORMULA .. 21% 43% 15% 23%15%11. ALOE VERA (Acemannan) .......15%12. NONI (Morinda Citrifolia) ... 15%rin i da) (Mo Non4Life4Lifeeaa mTransfer TransferVe r tru na c Factor Factor lo s AloeAdvanced Plus i EchCoSource: Jeunesse Inc. - Institute of Longevity Medicine, California, USA 3. Evidence from Clinical Studies Blokhin Russian Oncology Research Center, Russian Academy of Medical SciencesTransfer Factors effect theactivation of NK CellsSimilar to the LymphokineInterleukin-2IL2 are artificially activated NKcells used in cancer therapyCost $US5000 per Rx or$US10,000 per month plus inhospital and doctor fees.(US$60,000 for 6 mths)IL2 side effects listed as:Adverse or Life ThreateningDr. Kisielevsky of the Russian Academy of MedicalSciences stated, "The 4Life sample [Transfer FactorAdvanced Formula] activated NK (natural killer) cellactivity more than the Interleukin-2 (IL2) drug used asthe standard. This discovery has attracted theattention of The International Scientific and TechnicalCenter (ISTC) of Russia. 4. Evidence from Clinical Studies 7 years Scientific Study on 196 productsTEST RESULTS PUBLISHED IN JANA (Journal of American Nutraceutical Association)In the function of PREVENTING & OVERCOMINGDiseases, TRANSFER FACTOR is 8 TIMES MORE EFFECTIVE THAN LINGZHI / GANO 10 TIMES MORE EFFECTIVE THAN ECHINACEA 15 TIMES MORE EFFECTIVE THAN CORDYCEPS 19 TIMES MORE EFFECTIVE THAN COLOSTRUM / IgG 29 TIMES MORE EFFECTIVE THAN NONI & ALOE VERA 30 TIMES MORE EFFECTIVE THAN SPIRULINA, SEA-CUCUMBER, GINSENG, MACA, ROYAL-JELLY, CHLORELLA,ALFALFA, GINKGO, GREEN TEA, WHEAT-GRASS,CHLOROPHYLL, GOTU-KOLA, BEE-PROPOLIS, GRAPESEED,.. & MANY OTHERS! Source: Jeunesse Inc. - Institute of Longevity Medicine, California, USA 5. 6 6. Evidence from Clinical StudiesSCIENTISTS CALL IT MIRACLE MOLECULE Clinical Validation produced by the Ministry of HealthRussian FederationFIRST TIME IN HISTORY: Nutritional Supplement gets Approval byHealth Ministry of Russia for use inAll Hospitals & Clinics (31 July 04) 7 7. What can Transfer Factor do for you?3BALANCE 8. What can Transfer Factor do for you?1Educates Recognize Internal and external causes of disease. Respond contains immunity codes to help immune system defeat threats by killing them. Remember memory molecules help them remember pathogens when they come back.Recognize RememberRespond 9. Transfer Factor Plus Tri-Factor Formula + Herbs10 10. Third function of Transfer Factor is Regulating or Balancing your Immune System OVER REACTIONAUTO IMMUNEALLERGICDISEASES TransferREACTION(Hay fever, eczema, (Type 1 diabetes, rheumatoid Factor asthma, sinusitis)arthritis, psoriasis, multiplesclerosis, lupus Scleroderma, inflammatory bowel disease) It balances the immune system!CANCERINFECTION(Chronic fatigue, (From viruses, bacteria, fungi hepatitis, HIV, and parasites) shingles, tuberculosis) TransferFactorUNDER REACTION 11. Transfer Factors are Compliant w/ StandardsNo Contra-indication No Overdose No Side Effects US FDA Phil FDA Halal.R. A.S G 12 12. Evidence Based Clinical Studies LEVEL 1 CATEGORY A PHASE 3: INTERNATIONAL STUDIES AMAZING RESULTSLevel I Category A Phase III W/ HEPATITIS BMarch 1999, Monterrey, Nuevo Leon 25 YEARS OF CLINICAL EXPERIENCE WITHTRANSFER FACTORS1,647 PATIENTSA STATISTICALLYSIGNIFICANTINCREASE OFSURVIVALback 13 13. What Doctors & Scientists Say About TF"There is NO OTHER PRODUCT in a nutritional substance, NOR a drug, that has THIS KIND OF POWER and ability to affect our immune system. With the increase of killer viruses, mutated germs, super-resistant germs, and food contaminations, our only hope and defense, mustlie within our own immune system." -- Darryl See, MDAssociate Clinical Professor W.H.O. ( World Health Organization)Western Europe, Dr. See received his degree from the University ofCalifornia, Irvine. Academic appointments include: Assistant/AssociateClinical Professor of Medicine: Investigator, California CollaborativeTreatment Group: and Infectious Disease Consultant, LiverTransplantation Service. He has received contracts, grants, andresearch awards from Harvard Biotechnology, Pfizer Pharmaceuticals,Darryl See M.D. Upjohn Pharmaceuticals, Roche Molecular Systems,, National Institutesof Health, Department of Defense, and more. 14. Evidence Based Clinical StudiesLEVEL 3 CATEGORY A PHASE III Conducted by Doctors On Stage 4 cancer patients Start prognosis: Patients had 3.7 months to live.Results after six months: 16 out of the 20 patients studied are in remission, either improving or in stable condition. Level 3 Category A Phase III 15. Evidence Based Clinical StudiesLEVEL 3 CATEGORY A PHASE 3:Level 3 Category A Phase IIIMary Anne Myers, aged 45, has diabetes and was on 500mg ofGlucophage. She started taking 8 Transfer Factors per day andsprinkling 2 capsules directly on the wound for one week. Shesnow taking 6 capsules per day and continue sprinkling TransferFactor on the wound. Here are the remarkable results in justLESS THAN 4 WEEKS . 16. Evidence Based Clinical Studies LEVEL 3 CATEGORY A PHASE 3: RONALD,SEVEREINDONESIAINFECTION 11 Dec 06 7 Jan 0720 Jan 07Ronald, 28 years, met an accident with four of his fingers.Due to infection, doctors advised amputation to control complications.Fortunately, another Doctor (Dr. Eduard) a TF Advocate, recommended 6Capsule of TF Plus & 2 to add on the wound.Within just 3 days, doctors were shocked as not to see any sign of infection onhis fingers - thereby immediately retracting the earlier decision to amputate.In just within 6 weeks, his fingers were back to normal. 17. His latest discovery is aproduct called TransferFactor, sourced from colostrumfound in mothers and cows milk, eggs,and chickens. According to Fernandez,Transfer Factor contains theinformation molecule that educates theimmune system.With Transfer Factor,he points out, apersons immunesystem is able to correctitself.He cites the case of hisL-R: Dr. Ricardo Fernandez with Dr. Elizabeth Ifurung, USmother, now 90, whose heartand body were strengthened byAmbassador Harry Thomas, Dr. J. Ongsiako, and Cherry MiguelCoQ10 and who was able toDr. Ricardo Fernandez, MD, Chairman regain her vitality afterof Makati Medical Centers Department taking Transfer Factor.of Otonrhinolaryngology (ear, nose, and Now, believe it or not,throat) comes from a family of doctors. His father, she is back to her oldthe late Dr. Manuel C. Fernandez, was one of thefounders of MMC and a brother, Manuel Jr., specializes in self!- Phil. Star, July 31, 2012 by Alicecosmetic surgery at the same hospital.Reyes, Health & Family Section 18. DR. LUDGERIO TORRESCardiologist & CardiacSurgeonFormer Director,Philippine Heart CenterFor 13 YearsClinic Hours: Mon Fri 6-8pm Rm400(Except Thu)UST ProfessorFormer TOYMMagna Cum Laude,Graduate of USTL-R: Dr. Ricardo Fernandez with Dr. Elizabeth Ifurung, USAmbassador Harry Thomas, Dr. J. Ongsiako, and Cherry MiguelMedicineTrained at HarvardUniversity MedicalSchool, USAIndependentDistributor, 4LifeResearch Phil LLC(whole family) 19. Two patients of mine who had symptoms of heartattack showed blocked coronary arteries oncoronary angiogram. After giving TF Tri-Factor at2cap 3x a day for 3 months, the patients decided toundergo angioplasty. During the angioplasty, therewas clearing of blockage of one vessel so instead ofhaving 2 stents, only one stent was used. Ifprolonged intake was done, probably no need to doangioplasty. - DR. LUDGERIO TORRES 20. Evidence Based Clinical StudiesLEVEL 1 CATEGORY A PHASE 3: LOCAL STUDIESMon, pabiliAMAZING RESULTS WITH LEPROSY: RESOLVED IN 3 MONTHSMA. Luisa Venida MD, Dermatologistng MagicPRESIDENT, SKIN RESEARCH FOUNDATION OF THEPHILIPPINES MOST OUTSTANDING PHYSICIAN, 2003 PMAAwardee1ST TO STUDY 100% RESOLUTION FOR LEPROSY WITHTRANSFER FACTOR as ADJUVANT THERAPYNEW DOSAGING: 8,6,5,4,3,2 DAILY EVERY 2 WEEKS Level I Category A Phase III 21. Evidence Based Clinical StudiesLEVEL 1 CATEGORY A PHASE 3:AMAZING RESULTS WITH LEPROSY: RESOLVED IN 3 MONTHS Level I Category A Phase III 22. Evidence Based Clinical StudiesLEVEL 1 CATEGORY A PHASE 3:AMAZING RESULTS WITH LEPROSY: RESOLVED IN 3 MONTHS Level I Category A Phase III 23. Dx. Churg Straus Syndrome Severe Asthma Severe VasculitisTx. Transfer Factor Tri-Factor 6 cap/day Discharged from hospital in 3 days Clear finger in 2 weeks32 24. WHAT DOCTORS SAY ABOUT TFKillerT-Cells JAMES MARTINEZ, M.D., INTERNISTMember, American Society of Hypertension and Philippine US AID Scholar- UVA University of Virginia, Charlottesville Society of Hypertension Virginia, USA Howard University, Washington D.C. USAAmerican Diabetes Association and Philippine Diabetes University of Arkansas for Medical Sciences, Arkansas USAAssociationAmerican Medical Informatics AssociationPrivate Medical Practitioner: EL ROI MEDICAL CLINIC American Academy of Family Physicians AND DIAGNOSTIC CENTER Inc. Kamuning Quezon City 25. Evidence Based Clinical StudiesLEVEL 1 CATEGORY A PHASE 3: LOCAL STUDIESAMAZING RESULTS WITH HEPATITIS BVS. NO CURE FROM WESTERN MEDICINE Left Photo: Woman suffering from Liver Cancer caused by Hepatitis B. (Courtesy of Patricia Walker, MD, Ramsey Clinic Associates, St. Paul, MN) Above Photo: "Section of liver damaged by HBV. Note the enlarged cells & blistering of the capsular surface." http://www.vaccineinformation.org/photos/hepbuta002.jpg Copyright, Anthony Demetris, MD Director, Division of Transplantation Pathology, University of Pittsburgh Medical Centerback 34 26. Antibodies Surface Antigen forHepa B nowREACTIVE,thus Hepa B NEGATIVE In just2 Months, the firstrecordedlabtest In the Phil. Note: Nowmore than 10 successful cases & counting! 27. Evidence Based Clinical StudiesLEVEL 1 CATEGORY A PHASE 3: LOCAL STUDIESAMAZING RESULTS WITH HEPA B: RESOLVED IN 3 MONTHSTRIPLE BENEFITS: TF & INTERFERON REGIMENSAVINGS: 80% (From P480,000/48 weeks to P97,070/8 weeks only). Save P382,930.SPEED: Treatment duration cut from 1 year to only 2 months.SAFETY: Side effects of Interferon reduced if not eliminated. STANDARD TREATMENT (ST) WITHOUT TF (48-week Interferon alpha 2a or 2b)Interferon 2 vials of 3 MIU*/week x P5,000/vial or P10,000/week x 48 weeks = P480,000 TF & STANDARD TREATMENT COMBINATION (8 weeks only) TF 6 cap/day x 60 days = 360 caps or6 bottles@P2,845 = P17,070 Interferon 2 vials of 3 MIU*/week x P5,000/vial or P10,000/week x 8 weeks =P80,000 TOTAL COSTP97,070 SAVINGS P382,930SAVINGS = 80%*MIU=Million International Units, Rocheback 41 28. home Evidence Based Clinical Studies MORE & MORE DOCTORS ARE BECOMING ADVOCATES A skeptic beforeDR. ALEX L.Tan, MD, FPCS,FPSGSSurgical OncologistBut now a believer! 42 29. Evidence Based Clinical StudiesMORE & MORE DOCTORS ARE BECOMING ADVOCATESRECURRING POST MASTECTOMY BREAST CANCER RIGHT BREAST AREA RECOMMENDED DOSAGE: 6 DAYS OF 15 CAPSULES TF PLUS / DAYBEFORE 30. Evidence Based Clinical StudiesMORE & MORE DOCTORS ARE BECOMING ADVOCATESRECURRING POST MASTECTOMY BREAST CANCER RIGHT BREAST AREA AFTER 31. Evidence Based Clinical StudiesMORE & MORE DOCTORS ARE BECOMING ADVOCATESRECURRING POST MASTECTOMY BREAST CANCERRIGHT BREAST AREABefore TF TreatmentAfter TF Treatment 32. Evidence Based Clinical StudiesMORE & MORE DOCTORS ARE BECOMING ADVOCATES A skeptic for 3 years DR. CATHERINE MENDOZAPEDIATRICIAN But now a believer! 46 33. TESTIMONY ON PRIMARY COMPLEXThis is a multi drug resistant TB case (MDRTB)treated with Triple Anti-Kochs regimen (Isoniazid, Refampicin & Pyrazinamide)but showed no improvement. Upon follow-up with a frank case of exposure to mother with active Tuberculosis, untreated, non-compliant to treatment, a fourth drug of Ethambutol was added to the re-started Triple Anti-Kochs but still not much clinical improvement.PHYSICIAN: DR. CATHERINE MENDOZA,PEDIATRICIANPATIENT: ROBERT N., 5 YO MALE (2009, WCMC)REGIMEN:TF ADVANCED 1 CAPSULE 2 X A DAYTriple Anti-Kochs Regimen 34. TESTIMONY ON PRIMARY COMPLEX This is a multi drug resistant TB case (MDRTB)*treated with Triple Anti-Kochs regimen (Isoniazid, Refampicin & Pyrazinamide)but showed no improvement. Upon follow-up with a frank case of exposure to mother with active Tuberculosis, untreated, non-compliant to treatment, a fourth drug of Ethambutol was added to the re-started Triple Anti-Kochs but still not much clinical improvement.PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIANPATIENT: ROBERT N., 5 YO MALE (2009, WCMC)REGIMEN:TF ADVANCED 1 CAPSULE 2 X A DAYTriple Anti-Kochs RegimenRESULT : remarkable clinical improvement:weight gain, resolution of pulmonary symptoms,good appetite after 3 weeks.Note: *more than 200 SIMILAR SUCCESSFUL CASES ABOVE with FULL 35. TESTIMONY ON ADULT TB CASE & NO HISTORY OF CHILDBIRTHPHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIANPATIENT: SUSAN O., 33 YO FEMALE (2009, WCMC)REGIMEN:TF ADVANCED 2 CAPSULE 3 X A DAYTriple Anti-Kochs Regimen 36. TESTIMONY ON ADULT TB CASE & NO HISTORY OF CHILDBIRTHPHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIANPATIENT: SUSAN O., 33 YO FEMALE (2009, WCMC)REGIMEN:TF ADVANCED 2 CAPSULE 3 X A DAYTriple Anti-Kochs RegimenRESULT : remarkable clinical improvement:resolution of pulmonary symptoms after 3 weeks.BONUS: In 2010, patient discovered shes pregnantand gave birth to a healthy baby girl after 6 years ofwaiting. 37. TESTIMONY ON STAGE 4 DENGUEHEMORRAHGIC FEVER WITH MUCUCUTANEOS AND RENAL (KIDNEY) BLEEDING PLATELET COUNT ONLY: 16,000PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIANJULIET S., 21 YO FEMALE (2008, ST. LUKES HOSP.)REGIMEN:TF PLUS 5 CAPSULES 3 X A DAY 38. TESTIMONY ON STAGE 4 DENGUEHEMORRAHGIC FEVER WITH MUCUCUTANEOS AND RENAL (KIDNEY) BLEEDING PLATELET COUNT ONLY: 16,000PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIANJULIET S., 21 YO FEMALE (2008, ST. LUKES HOSP.)REGIMEN:TF PLUS 5 CAPSULES 3 X A DAYRESULT: PLATELET COUNT IN 3 DAYS = 300,000Note: More than 200 SUCCESSFUL DENGUE CASES with FULL RECOVERY UNDR CATHERINE MENDOZA todate and counting! 39. In its Methodoligical Letter (Moscow 2004), The Ministry of Health and Social Development of the Russian Federation published the following:"Acquired Immunorehabilitation Syndrome (AIDS) is one of the mostserious problems confronting medicine. For HIV patients immunemodulation therapy (i.e. the restoration of normal immune function) isaimed at altered immune mechanisms and at the pathogenic agent(s).The results of studies conducted showed that TRANSFER FACTOR (TF)PLUS treatment significantly improved the immune status of HIV patients.The product also proved useful in other aspects of therapy as for examplethe level of circulating immune complexes (CIC) decreased to normal valuesin 50% of patients receiving TF PLUS."PLUS 40. Transfer Factors in HIV-Infected PatientsGranitov V.M., Karbysheva N.V., Sultanov L.V., McCausland C., Oganova E., The Altay State Medical University; The Altay Regional Center for Prophylaxis and Treatment of AIDS, Russian FederationINTRODUCTION: Included in this study were 25 HIV-infected patients(20 male and 5 female), ages 19 to 56 (15 patients ages 21-25). Individuals were classifiedaccording to V.I. Pokrovskys classification (1989) for HIV-infection. Eight (8) patientswere diagnosed to have stage 2B, thirteen (13) patients were stage 2C, three (3) patientswere stage 3A and one (1) was stage 3B. Infection periods were as follows: nine (9)patients were infected 1 year ago, four (4) were 2 years ago, four (4) were three yearsago, six (6) were 5 years ago and two (2) were 6 years ago.OBJECTIVE: The purpose of this study is to serve as an initial trial in evaluating theeffects of enhanced transfer factors supplementation on HIV-infected patients.METHODOLOGY: The experimental group (15 patients), who did not receiveantiretroviral or immuno-correcting therapy, received enhanced transfer factors providedby 4Life Research, USA. They were administered one capsule twice a day for 7 days. Thecontrol group (10 patients) consisted of HIV-infected patients taking cycloferon in thefollowing dosage schedule: 1st, 2nd, 4th, 6th, 8th, 10th, 12th and 14th days. Beforetreatment and 7 to 10 days after the treatment an evaluation was carried out to accessthe immune status of the patient groups and to determine cytokine (interleukin 1b (IL-1b), tumor necrosis factor (TNF-a) and g-interferon (IFN-g) levels. 41. Transfer Factors in HIV-Infected PatientsGranitov V.M., Karbysheva N.V., Sultanov L.V., McCausland C., Oganova E., The Altay State Medical University; The Altay Regional Center for Prophylaxis and Treatment of AIDS, Russian FederationRESULTS: In the experimental group, it was found that after treatment with enhancedtransfer factors there was an increase of lymphocytes in 13 patients, an in crease of CD3cells in 15 patients, an increase of CD4 cells in 14 patients and an increase in CD8 cells in12 patients. Immuno-regulating index (IRI) persisted on the same level in 3 patients wasincreased in 10 patients and decreased in 7 patients. IgG was reduced in 16 patients andIgM was within normal limits in all patients. An increase of IL-1b and IFN-7 was noted inall patients treated with transfer factors. Circulating Immune Complex (CIC)levels dropped to normal levels in 10 of the patients. In the controlgroup an increase of lymphocytes was noted in only 3 patients. A decrease of CD3, CD4and CD8 cells was noted in 6 patients. IRI persisted on the same level or decreased. CIClevels dropped to normal in 3 patients, increased in 6 patients, there was no change in 1patient. The occurrence of increases and decreases of IgG were equal.CONCLUSION: We conclude that transfer factors therapy considerablyimproves the immune status of HIV-infected patients and can berecommended in combating the pathogenesis of the disease. Furtherstudies are needed to determine optimal therapy, the necessity to repeat courses of thetreatment and the frequency of therapy needed. 42. IX NATIONALCONGRESS OF DIETOLOGISTS ANDNUTRIOLOGISTS THAT TOOK PLACEIN MOSCOW, RUSSIA DECEMBER 3-5,2005 43. Transfer Factor is a Modifier of Biological AgeA.G. Chizhov, V.A. Santalova Russian Peoples Friendship University, MoscowINTRODUCTION: There is a close link between the decrease of functional activity ofthe immune system and aging. Thus, we decided to study immunomodulators to determineto what extent they may affect biological age indices. A new immune theory of aging(V.I.Dontsov, V.N. Krutko, 2002) points to the role of specific T-lymphocytessubpopulations in sustaining a certain level of normal cellular growth in the body and dwellson the importance of their functional decrease havinga strong impact on aging. Stimulation of the function of these cells by Transfer Factor (TF),an immunomodulator produced by 4Life, USA, seemed a plausible method of treatingaging.OBJECTIVE: The evaluation of the role TF in the process of aging is at the basis of thisstudy.METHODOLOGY: Twelve (12) men aged 55-73 were included in the study. A dose of300 mg. of the TF product was given daily with meals 5 times a week for 6 weeks.Biological age was determined using the PK method (Diagnostics of aging: biologicalage (National gerontology center, Moscow)). The following biomarkers were used formaking the determinations: AP (arterial pressure), pulse wave velocity, VC (vital pulmonarycapacity), static balance, Shtanges test, adaptation testing, body mass, left hand strength,Shultes test, Vekslers test, neuromuscular test, hearing frequency threshold and the SANsquestionnaire. The functional activities of body systems were evaluated by means ofNakatanis electropuncture diagnostics. 44. Transfer Factor is a Modifier of Biological AgeA.G. Chizhov, V.A. Santalova Russian Peoples Friendship University, MoscowRESULTS: Chronological age of the group was 63.50.7. Before theuse of TF the biological age of the group differed from chronological by-4.2 0.6 years. The majority of men demonstrated a decrease in thefunctional activity of endocrine and of immune systems as well ashyperfunction of the liver and of urinary bladder and hypofunctionpancreatic.CONCLUSION: The study showed that initially disturbed bodysystem functions were significantly normalized. After the course of TFtreatment the difference between biological and chronological age was(-8.2) 0.5 years(prejuvenation effect of 4 years in just 6 weeks! 45. Evidence Based Clinical StudiesLEVEL I CATEGORY A PHASE 1 Level I Category A Phase I 46. Evidence Based Clinical StudiesLEVEL II CATEGORY B PHASE IIILevel 2 Category B Phase III 47. Evidence Based Clinical StudiesLEVEL II CATEGORY B PHASE IIILevel 2 Category B Phase III 48. Evidence Based Clinical StudiesLEVEL II CATEGORY A PHASE IIILevel 2 Category A Phase III 49. Evidence Based Clinical StudiesLEVEL II CATEGORY B PHASE IIILevel 2 Category A Phase III 50. March 1999, Monterrey, Nuevo Leon 51. TESTIMONY ON SEVERE ATOPICDERMATITIS(A.K.A. SKIN ASTHMA FOR 22 YEARS)MAYA C., 22 YO, FEMALE (2008)REGIMEN: TF TRI-FACTOR DOSAGE: 2 CAPS 2 X A DAYOthers: Skin Ointment 52. TESTIMONY ON SEVERE ATOPICDERMATITIS(A.K.A. SKIN ASTHMA FOR 22 YEARS)MAYA C., 22 YO, FEMALE (2008)REGIMEN: TF TRI-FACTOR DOSAGE: 2 CAPS 2 X A DAYOthers: Skin OintmentRESULT IN 21 DAYS: CLEAR SKIN 53. Maya Cabuang 54. TESTIMONY ON FERTILITY(10 WOMEN AGES: 24-33NO HISTORY OF CHILDBIRTH ) PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNE REGIMEN: TF TRI-FACTOR 2 CAPS 3 X A DAY OTHER MEDICINES 55. TESTIMONY ON FERTILITY(10 WOMEN AGES: 24-33NO HISTORY OF CHILDBIRTH ) PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNE REGIMEN: TF TRI-FACTOR 2 CAPS 3 X A DAY OTHER MEDICINES RESULTS: PREGNANCY IN 2 MONTHS 56. TESTIMONY ON MILD ALZHEIMERS DISEASE(ON DIAPERS FOR TWO YEARS UNAWARE AND NO CONTROL OFBOWEL MOVEMENT)AMY T.., 76 YO FEMALE (2009, ST. LUKES)REGIMEN:TF ADVANCE 2 CAPS 3 X A DAYTF RIOVIDA 30 ML 3 X A DAY 57. TESTIMONY ON MILD ALZHEIMERS DISEASE(ON DIAPERS FOR TWO YEARSUNAWARE AND NO CONTROL OF BOWEL MOVEMENT)AMY T.., 76 YO FEMALE (2009, ST. LUKES) REGIMEN: TF ADVANCE 2 CAPS 3 X A DAY TF RIOVIDA 30 ML 3 X A DAY RESULTS: IN 3 WEEKS, SIGNALS FOR BOWEL MOVEMENT AND IS GETTING AWARE OF HER SURROUNDINGS & GETTING JEALOUS AGAIN. TODAY, SHES WELL & TOURING IN THE U.S. 58. TESTIMONY ON EPILEPTIC WOMAN WITH 6-8 SEIZURES A DAY (SOMETIMES JUMPS OUT OF THEWINDOW)JANICE M., 24 YO FEMALE (OCT 2011,PALAWAN)REGIMEN:TF PLUS 2 CAPS A DAYRESULTS: 59. TESTIMONY ON EPILEPTIC WOMAN WITH 6-8 SEIZURES A DAY (SOMETIMES JUMPS OUT OF THEWINDOW)JANICE M., 24 YO FEMALE (OCT 2011,PALAWAN)REGIMEN:TF PLUS 2 CAPS A DAYRESULTS: IN 4 DAYS, SEIZURES STOPPEDCOMPLETELY 60. TESTIMONY ON KIDNEY STONES(Size: 1.2cmx0.40cm)BENG P., 61 YO FEMALE (2011, MAKATI)REGIMEN:TF RIOVIDA80ML 3 X A DAY FOR 4 DAYSRESULT: 61. TESTIMONY ON KIDNEY STONES(Size: 1.2cmx0.40cm)BENG P., 61 YO FEMALE (2011, MAKATI)REGIMEN:TF RIOVIDA80ML 3 X A DAY FOR 4 DAYSRESULT: IN 10 DAYS, A KIDNEY STONE CAMEOUT NATURALLY 62. TESTIMONY ON ERECTILE DYSFUNCTION (15 YEARS E.D., AND RECENTLYUNDERWENT BY-PASS OPERATION) PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNEPATIENT: MANUEL D., 73 YO MALE (2009)REGIMEN:TF TRI-FACTOR 2 CAPS 3 X A DAYTF CARDIO 1 CAP 3 X A DAY 63. TESTIMONY ON ERECTILE DYSFUNCTION (15 YEARS E.D., AND RECENTLYUNDERWENT BY-PASS OPERATION) PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNEPATIENT: MANUEL D., 73 YO MALE (2009)REGIMEN:TF TRI-FACTOR 2 CAPS 3 X A DAYTF CARDIO 1 CAP 3 X A DAYRESULTS: NORMALCY IN 1 MONTH 64. TESTIMONY ON STROKE(HALF-BODY PARALYZED, CANT TALK)ANGELITO M., 46 YO, MALE (2010)REGIMEN:TF CARDIO: 3 CAPS 3 X A DAYTF RIOVIDA: 30 ML 2X A DAY 65. TESTIMONY ON STROKE(HALF-BODY PARALYZED, CANT TALK)ANGELITO M., 46 YO, MALE (2010)REGIMEN:TF CARDIO: 3 CAPS 3 X A DAYTF RIOVIDA: 30 ML 2X A DAYRESULT: RECOVERED ON 3RD DAY 66. TESTIMONY ON KIDNEY FAILURE(EXTREMELY WEAK, BEDRIDDEN, CANNOT URINATE, ON DIALYSIS 3X AWEEK)FR. JOE GARDUCE, 65 YO (PALAWAN) REGIMEN:TF CARDIO: 2 CAPS A DAYTF TRI-FACTOR : 6 CAP 3X A DAYDIET: NO MEAT ALL VEGETABLES & STEAMED FISHRESULT: 67. TESTIMONY ON KIDNEY FAILURE(EXTREMELY WEAK, BEDRIDDEN, CANNOT URINATE, ON DIALYSIS 3X AWEEK)FR. JOE GARDUCE, 65 YO (PALAWAN) REGIMEN:TF CARDIO: 2 CAPS A DAYTF TRI-FACTOR : 6 CAP 3X A DAYDIET: NO MEAT ALL VEGETABLES & STEAMED FISH RESULT: FULL OF ENERGY IN 2 WEEKS, &ON 2ND MONTH: CAN NOW SAY MASS 3 X A DAYAND NOW PLAYS BASKETBALL EVERYDAY. 68. TESTIMONY ON 4 CLOGS IN THEHEART ARTERIES DUE FOR ANGIOPLASTY (HOSPITALIZED DUE FOR HEARTOPERATION COSTING PHP1.2 MILLION)EDWARD D., 56 YO (ILOILO)REGIMEN: TF CARDIO: 2 CAPS 3X A DAY TF RIOVIDA : 30ML 3X A DAYRESULT: 69. TESTIMONY ON 4 CLOGS IN THEHEART ARTERIES DUE FOR ANGIOPLASTY (HOSPITALIZED DUE FOR HEARTOPERATION 56 YO (ILOILO) EDWARD D., COSTING PHP1.2 MILLION) REGIMEN: TF CARDIO: 2 CAPS 3X A DAY TF RIOVIDA : 30ML 3X A DAY RESULT: LABTEST SHOWED NO MORE CLOGS ON THE 3 DAY. SURGERY WAS CANCELLED,RD MY BROTHER WAS DISCHARGED FROM THE HOSPITAL AND WENT STRAIGHT TO WORK - MSGR. JOSE DELFIN, PALAWAN 70. REV. MSGR. JOSE DELFIN 71. Core Products No Contra-indication No Contra-indication No OverdoseNo Overdose No Side EffectsNo Side Effects 72. Transfer Factor AdvanceTri-Factor FormulaContains Pure Transfer FactorContains Pure Transfer FactorRecommended for:Recommended for:Auto Immune DysfunctionAuto Immune DysfunctionFor PreventionFor PreventionSafe for infantsSafe for infants 4LIFE TF TRI-FACTOR ADVANCE ITEM# 170024070 BFAD# FR-63738 HALAL CERTIFIED Islamic Food &Nutrition Council of America PATENT# 6,468,534 73. Transfer Factor Plus Tri-Factor Formula + HerbsTri Factor Advance + the most powerful Tri Factor Advance + the most powerfulproprietary blend of herbs that more proprietary blend of herbs that morethan double the boosting power of Tri- than double the boosting power of Tri-Factor Advance. Factor Advance.4LIFE TF TRI-Recommended for:Recommended for:FACTOR PLUSInfections ITEM# 170024075InfectionsBFAD# FR-56143 HALAL CERTIFIED Islamic Food &Chronic ailmentTerminal DiseasesChronic ailmentTerminal DiseasesNutrition Council of America PATENT# 6,468,534 & 6,866,868Ingredients: Ingredients:Beta Glucans, Maitake, Shitake Mushroom, AloeBeta Glucans, Maitake, Shitake Mushroom, AloeVera Mannans, Olive leaf extract, Cordyceps, IP6Vera Mannans, Olive leaf extract, Cordyceps, IP6 74. Transfer Factor Plus Tri-Factor Formula + Herbs + Zinc 75. Transfer Factor RioVida Tri-Factor Formula + ORAC Rich BerriesUSDA Top-Scoring Fruits & Vegetables ORAC units per 100 grams (about 3 ounces)1 Acai18,5002 Pomeranates 10,5003 Prunes5,7704 Raisins 2,8305 Blueberries 3,2006 Blackberries2,0367 Kale1,7708 Strawberries1,5409 Spinach 1,26010Apples (red)1,40011Raspberries 1,22012Purple grapes 1,10013Brussels sprouts98014Plums 94915Alfalfa sprouts 93016Broccoli flowers89017Beets 84018Oranges 75019Red bell pepper 71020Red grapes73921Cherries67022Kiwi fruit602 76. Transfer Factor RioVida Tri-Factor Formula + ORAC Rich Berries 77. 4LifeTransfer Factors Factor GlucoachTargeted Transfer4LIFE TF GLUCOACH ITEM# 170029001 BFAD# FR-56461 HALAL CERTIFIED Islamic Food & Nutrition For those individuals with levels already inCouncil of America PATENT# 6,468,534 & 6,866,868the normal range,. 110 78. 4Life Glutamine Prime 79. 4Life BioEFAOur Latest Product 80. home enummi Skin Care withTransfer Factor 81. home Important Frequently Asked Questions 82. homeIs Transfer Factor safe for Q:children? A: YES! 83. home Why do 4Life Transfer Factor Q: products have disclaimerson its labels? A: Because it is required by the Bureau of Food & Drugs (BFAD). 84. home Can I take Transfer Factor Q:even if Im currently takingpharmaceutical drugs? A: YES! You can take Transfer Factor as an adjunct to your existing medicine. 85. home Can we recommend TransferFactor Q:to people taking immunosuppressants? A: NO They are the only people who are not recommended to take Transfer Factor. 86. home I am allergic to milk and eggs,Q: can I take Transfer Factor? A: YES! Allergy is an auto-immune dysfunction. COLOSTRUM 1. Water 2. Vitamins / Minerals 3. Protein 4. Fat 5. Carbohydrates (Lactose) 6. Immunoglobins 7. Slight Growth Hormones 8. Transfer Factors 87. home Q: How much product should I take? A: Healthy: Daily recommended value Sick: 2X Daily recommended value Chronic Ailment: 3X Daily recommended value Terminally ill: 4X to 5X Daily recommended value 88. homeCan you overdose on Q: Transfer Factor Products? A: NO!Base on clinical study at 2,000X ofthe Daily Recommended Value or at6,000 capsules level of toxicity is ZERO. 89. homeQ: How much are the products?SRPSRPWholesale Wholesale TF Plus Php3,820 (90cap)Php 51.00/CapsulePhp 43.00/Capsule TF Tri-Factor Php2,845 (60cap) Php 57.00/Capsule Php 47.00/Capsule TF RioVida Php4,200 (2x500ml) Php 168.00/ounce Php 140.00/ounce TF Riovida Burst Php2,225 Php 178.00/sachetPhp 149.00/sachet TF Cardio Php3,472 (120cap) Php 35.00/CapsulePhp 29.00/Capsule TF GluCoach Php3,472 (120cap) Php 35.00/CapsulePhp 29.00/Capsule TF Glutamine Php2,690 (180cap))Php 15.00/Capsule BioEFA Php1,320 (60cap)Php 22.00/Capsule